Delving into the Latest Updates on Chengdu Weisijin Biomedical Technology Co Ltd. with Synapse

Overview

Tags

Neoplasms

Infectious Diseases

Digestive System Disorders

mRNA vaccine

Prophylactic vaccine

Protein drugs

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	13
Infectious Diseases	12
Endocrinology and Metabolic Disease	5
Hemic and Lymphatic Diseases	1
Immune System Diseases	1

Top 5 Drug Type	Count

mRNA vaccine	17
Prophylactic vaccine	5
Vaccine	4
Protein drugs	4
Gene editing	3

Top 5 Target	Count

Viral proteins	4
EBV Protein	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 14 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

7

22

Preclinical

IND Application

3

Phase 1 Clinical

Other

7

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

WGc-043 ( EBV Protein )	Epstein-Barr virus associated Neoplasms More	Phase 1
Hepatic Carcinoma Vaccine(WestGene)	Liver Cancer More	Phase 1
COVID-19 delta/omicron mRNA vaccine (WestGene)	COVID-19 More	Phase 1
WGv-0129	COVID-19 More	IND Application
WGc-0501	Solid tumor More	IND Application